MiMedx Group Inc (MDXG)
9.19
-0.03
(-0.33%)
USD |
NASDAQ |
Nov 22, 11:35
MiMedx Group Total Liabilities (Quarterly): 62.88M for Sept. 30, 2024
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 62.88M |
| June 30, 2024 | 62.14M |
| March 31, 2024 | 65.95M |
| December 31, 2023 | 96.33M |
| September 30, 2023 | 187.69M |
| June 30, 2023 | 189.04M |
| March 31, 2023 | 186.10M |
| December 31, 2022 | 189.42M |
| September 30, 2022 | 192.32M |
| June 30, 2022 | 182.27M |
| March 31, 2022 | 181.88M |
| December 31, 2021 | 187.85M |
| September 30, 2021 | 186.33M |
| June 30, 2021 | 194.28M |
| March 31, 2021 | 198.86M |
| December 31, 2020 | 202.18M |
| September 30, 2020 | 200.45M |
| June 30, 2020 | 128.05M |
| March 31, 2020 | 128.57M |
| December 31, 2019 | 132.77M |
| September 30, 2019 | 139.69M |
| June 30, 2019 | 145.63M |
| March 31, 2019 | 69.09M |
| December 31, 2018 | 73.19M |
| December 31, 2017 | 47.46M |
| Date | Value |
|---|---|
| September 30, 2017 | 36.24M |
| June 30, 2017 | 52.60M |
| March 31, 2017 | 59.46M |
| December 31, 2016 | 60.26M |
| September 30, 2016 | 58.39M |
| June 30, 2016 | 55.45M |
| March 31, 2016 | 62.98M |
| December 31, 2015 | 27.92M |
| September 30, 2015 | 25.40M |
| June 30, 2015 | 20.60M |
| March 31, 2015 | 19.70M |
| December 31, 2014 | 19.93M |
| September 30, 2014 | 16.06M |
| June 30, 2014 | 11.54M |
| March 31, 2014 | 11.11M |
| December 31, 2013 | 11.13M |
| September 30, 2013 | 9.758M |
| June 30, 2013 | 7.392M |
| March 31, 2013 | 6.259M |
| December 31, 2012 | 15.18M |
| September 30, 2012 | 14.35M |
| June 30, 2012 | 11.80M |
| March 31, 2012 | 14.36M |
| December 31, 2011 | 15.20M |
| September 30, 2011 | 11.70M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
62.14M
Minimum
Jun 2024
202.18M
Maximum
Dec 2020
157.77M
Average
186.22M
Median
Total Liabilities (Quarterly) Benchmarks
| CEL-SCI Corp | 15.60M |
| AIM ImmunoTech Inc | 10.68M |
| IGC Pharma Inc | 2.992M |
| NovaBay Pharmaceuticals Inc | 2.805M |
| Protalix BioTherapeutics Inc | 29.13M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 243.89M |
| Shareholders Equity (Quarterly) | 181.01M |
| Debt to Equity Ratio | 0.1051 |
| Current Ratio | 4.104 |
| Net Debt Paydown Yield | 0.69% |